Germline RBBP6 mutations in familial myeloproliferative neoplasms

Kralovics, 2003, Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease., Blood, 102, 3793, 10.1182/blood-2003-03-0885

Rumi, 2006, JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders., Cancer, 107, 2206, 10.1002/cncr.22240

Bellanné-Chantelot, 2006, Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders., Blood, 108, 346, 10.1182/blood-2005-12-4852

Landgren, 2008, Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden., Blood, 112, 2199, 10.1182/blood-2008-03-143602

James, 2005, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera., Nature, 434, 1144, 10.1038/nature03546

Kralovics, 2005, A gain-of-function mutation of JAK2 in myeloproliferative disorders., N Engl J Med, 352, 1779, 10.1056/NEJMoa051113

Pikman, 2006, MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia., PLoS Med, 3, e270, 10.1371/journal.pmed.0030270

Klampfl, 2013, Somatic mutations of calreticulin in myeloproliferative neoplasms., N Engl J Med, 369, 2379, 10.1056/NEJMoa1311347

Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2., N Engl J Med, 369, 2391, 10.1056/NEJMoa1312542

Lundberg, 2014, Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms., Blood, 123, 2744, 10.1182/blood-2014-01-550863

Maffioli, 2014, Looking for CALR mutations in familial myeloproliferative neoplasms., Leukemia, 28, 1357, 10.1038/leu.2014.33

Rumi, 2014, CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis., Blood, 123, 2416, 10.1182/blood-2014-01-550434

Delhommeau, 2009, Mutation in TET2 in myeloid cancers., N Engl J Med, 360, 2289, 10.1056/NEJMoa0810069

Ley, 2010, DNMT3A mutations in acute myeloid leukemia., N Engl J Med, 363, 2424, 10.1056/NEJMoa1005143

Carbuccia, 2009, Mutations of ASXL1 gene in myeloproliferative neoplasms., Leukemia, 23, 2183, 10.1038/leu.2009.141

Olcaydu, 2011, The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms., Haematologica, 96, 367, 10.3324/haematol.2010.034488

Saint-Martin, 2009, Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms., Blood, 114, 1628, 10.1182/blood-2009-01-197525

Olcaydu, 2009, A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms., Nat Genet, 41, 450, 10.1038/ng.341

Jäger, 2014, Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms., Am J Hematol, 89, 1107, 10.1002/ajh.23842

Oddsson, 2014, The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms., Leukemia, 28, 1371, 10.1038/leu.2014.48

Tapper, 2015, Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms., Nat Commun, 6, 6691, 10.1038/ncomms7691

Li, 2007, PACT is a negative regulator of p53 and essential for cell growth and embryonic development., Proc Natl Acad Sci USA, 104, 7951, 10.1073/pnas.0701916104

Lee, 1987, Human retinoblastoma susceptibility gene: cloning, identification, and sequence., Science, 235, 1394, 10.1126/science.3823889

Wallace, 1990, Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients., Science, 249, 181, 10.1126/science.2134734

Hussussian, 1994, Germline p16 mutations in familial melanoma., Nat Genet, 8, 15, 10.1038/ng0994-15